Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation for Rv2645 protein, and application thereof on aspects of tuberculosis diagnosis and reorganized BCG vaccines

A rv2645, protein technology, applied in the fields of molecular microbiology and infection immunology, can solve problems such as research difficulties, and achieve the effect of high application value, simple method and strong immunogenicity

Inactive Publication Date: 2015-01-21
WUHAN UNIV
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the large number of RD1-16 genes, the research is more difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation for Rv2645 protein, and application thereof on aspects of tuberculosis diagnosis and reorganized BCG vaccines
  • Preparation for Rv2645 protein, and application thereof on aspects of tuberculosis diagnosis and reorganized BCG vaccines
  • Preparation for Rv2645 protein, and application thereof on aspects of tuberculosis diagnosis and reorganized BCG vaccines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] The construction of each prokaryotic expression vector pET28a-RDs of embodiment 1RD10-14 district

[0054] 1.1 The design of primers for each RD gene, the specific primers required for construction are shown in Table 1:

[0055] Table 1. Primer sequences for each RD gene

[0056]

[0057]

[0058]

[0059]

[0060] Wherein, the underlined part is a restriction enzyme cutting site.

[0061] 1.2 Amplification and recovery of each RD gene

[0062] Using the genome of M.tb strain H37Rv (ATCC 25618) as a template, use the primers in the above table to PCR amplify each RD gene, and the reaction program varies according to the annealing temperature of each primer. Taking the amplification of the Rv2645 gene as an example, the PCR reaction program is: 95°C for 3min; 94°C for 20s, 58°C for 20s, 72°C for 20s, 30 cycles; 72°C for 3min; PCR products are detected by 1% agarose gel electrophoresis , Gel Purification Kit (Axygen) for recovery (operate according to kit p...

Embodiment 2

[0074] Expression and purification of the protein of interest in the recombinant plasmid of embodiment 2

[0075] 2.1 Expression of RD protein

[0076] Taking Rv2645 as an example, take 1 μL of pET28a-Rv2645 recombinant plasmid, add it to Escherichia coli expressing engineering strain BL21 competent, ice bath for 15 minutes, heat shock at 42°C for 90 seconds, ice bath again for 5 minutes, add 800 μL of LB liquid medium for shaking culture for 40 minutes, Take 100 μL coated kana-resistant LB solid plate (same as above). After overnight culture, pick positive clones and transfer them to 5 mL of LB liquid medium (kana concentration is 5 μg / mL) at 37°C, 200 rpm, and shake for 16 hours; Shake it in 250mL liquid medium, and add inducer IPTG when the absorbance value at OD600 is about 0.6, and the final concentration is 0.8mM. In a temperature-controlled shaker at 25°C, 200rpm, 20h; at the end of the induction culture, take 1mL of collected bacteria and 1mL of bacteria before induc...

Embodiment 3

[0079] Example 3 Determination of the ability of each RD protein to stimulate IFN-γ release

[0080] 3.1 ELISPOT detection of IFN-γ release level in preimmunized mice

[0081] The expressed and purified RD proteins were quantified by the Bradford method. BALB / c mice (specific mouse immunization scheme as shown in figure 1 (shown) was executed to obtain the spleen, and the mouse splenocytes were obtained after the erythrocytes were broken with AKT (erythrocyte lysate).

[0082] According to the instructions of the Mouse IFN-gamma ELISPOT pre-coating kit (for Daktronics). Spread 5×10 per hole 5 splenocytes, 5 μg of stimulator RD protein was added to each well, and cultured in a cell culture incubator for 48 hours. After the experiment, the 96-well plate was sent to Daktronics to read the number of spots.

[0083] 3.2 ELISA detection of IFN-γ release level of human PBMC

[0084] Wuhan Medical Assistance Center obtained whole blood from tuberculosis patients and separated PB...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses preparation for Rv2645 protein, and the application thereof on aspects of tuberculosis diagnosis and recombination BCG vaccines. According to the preparation for Rv2645 protein and the application thereof, the Rv2645 protein in a tuberculosis gene RD10-14 zone is found to have the ability of inducing high-level gamma interferon, and when used for the diagnosis of the serum antibodies, especially IgG4 subtype antibodies, of a tuberculosis patient, has prominent statistics difference compared with the serum antibodies of healthy people; as the dominant antigen of the mycobacterium tuberculosis, the Rv2645 protein has the function of inducing high-level cellular immunity and humoral immunity, and can be used as a novel diagnostic reagent for tuberculosis; the Rv2645 protein can further be used for novel recombination BCG vaccines or protein vaccines for tuberculosis, the constructed recombination BCG capable of expressing the Rv2645 protein has the function of antituberculous immunity protection. According to the preparation for the Rv2645 protein and the application thereof provided by the invention, the Rv2645 protein is proved to have potential application value when used for tuberculosis diagnosis and reorganized BCG vaccines, so that the preparation and the application thereof has significant economic benefits.

Description

technical field [0001] The invention belongs to the fields of molecular microbiology and infection immunology, and relates to the preparation of Rv2645 protein and its application in tuberculosis diagnosis and recombinant BCG vaccine. Background technique [0002] Tuberculosis (TB) caused by Mycobacterium tuberculosis (M.tb) is a widespread and harmful infectious disease. It is one of the three major infectious diseases in the world together with AIDS and malaria. One-third of the world's people have been infected with tuberculosis, and more than 1.7 million people die from tuberculosis every year. It consumes a lot of manpower and material resources to prevent and control TB. [0003] For a long time, the diagnosis of tuberculosis has relied on the tuberculin skin test, but this method cannot be used to distinguish tuberculosis patients from healthy people who have received the tuberculosis vaccine BCG. Although sputum culture is the gold standard for tuberculosis diagnosi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/35C12N15/31C12N15/70G01N33/569A61K39/04A61P31/06
CPCC07K14/35A61K39/00C12N15/70G01N33/5695G01N33/68
Inventor 章晓联罗微屈子璐
Owner WUHAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com